Chronic periodontitis (CP) is characterized by gingival inflammation and bone destruction. It has been reported that interferon-gamma (IFN-g) levels are high in CP patients; however, the IFN-g receptor (IFN-gR) has not been studied in gingival tissue from these patients. Objective: To evaluate IFN-g levels and IFN-gR expression in gingival tissue biopsies from chronic periodontitis patients compared with healthy subjects (HS). Material and Methods: Gingival tissues were obtained from all study subjects, CP (n=18) and healthy subjects (HS) (n=12). A tissue section of each study subject was 
Introduction C h r o n i c p e r i o d o n t i t i s ( C P ) i s a s t r o n g immunoinflammatory response to periodontal
pathogens influenced by metabolic disorders, 1,2 as well as genetic 3, 4 and environmental factors. 5 Chronic gingival and periodontal inflammations lead to attachment loss with a periodontal pocket formation and progressive alveolar bone destruction. 6, 7 Responding to the bacterial infection in periodontitis,
antigen-presenting cells (APC) produce IL-12 and IL-18. 8 Subsequently, IL-12 and IL-18 synergize and stimulate the production of interferon-gamma (IFN-g) in T and NK cells. with lepromatous leprosy has been described. 8, 13 In this regard, an increase in mRNA and IFN-g protein has been reported in gingival tissue, gingival crevicular fluid (GCF), and serum samples from CP patients compared to healthy subjects (HS). [14] [15] [16] [17] [18] [19] Regarding the expression of IFN-gR in CP, only studies of IFNgR1 polymorphisms exist and no association has been found for periodontitis. 20, 21 Therefore, the objective of this study was to evaluate IFN-g levels and the expression of IFN-gR in gingival tissue samples from CP patients compared to healthy subjects.
Material and methods

Study subjects
Thirty subjects who attended the Periodontal Clinic of the Dentistry School were recruited to participate in this study. Patients who had clinical features typical of chronic periodontitis (as described later), were enrolled consecutively. All subjects were in good general health and had not received previous periodontal therapy or taken antibiotics, immunomodulatory, or antiinflammatory drugs in the six months prior to the study. Pregnant women, smokers, patients who were undergoing antibiotic prophylaxis for dental treatment, patients with any systemic disease, or those who were on long-term medication that could affect the expression of gingivitis or periodontitis were excluded from the study.
11,22
The purpose of this study was explained to each subject before he/she agreed to participate, and their informed consent was obtained according to the World Medical Association Declaration of Helsinki v. 2002.
The study was approved by the Medical Ethical Review
Committee and all subjects gave their written approval before participating based on the General Health Law.
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Clinical examination
Clinical examinations were performed on all existing teeth of the participants and periodontal conditions
were assessed based on the following parameters:
sites with plaque (SP), bleeding on probing (BOP), probing depth (PD) and clinical attachment level (CAL).
The examination of all subjects was performed using 24 The gingival tissues were collected by routine periodontal surgery, as described below: two periodontist surgeons performed all operations. All patients were prepared with chlorhexidine gluconate for two minutes before the surgical procedure. 6 The surgical procedure was performed using a local anesthetic (2% articaine with 1:100,000 epinephrine). 6 For CP patients, sulcular
incisions were made on all teeth and mucoperiosteal flaps were designed in the lingual and palatal areas 
IFN-gR expression (immunohistochemistry)
The detection of IFN-gR1 and IFNgR2 was performed using a direct immunohistochemical method. Serial sections (6 mm×5 mm) from the formalin-fixed, paraffin-embedded blocks were used. Thin sections (5 μm) were deparaffinized in xylene, rehydrated through a graded series of ethanol and heated in citrate buffer (10 mM; pH 6.0) in a steamer for 30 minutes for antigen retrieval. After incubation with the primary antibody, each sample was incubated for 10 min with a biotinylated secondary antibody, followed by incubation with a streptavidin-peroxidase conjugate for 10 minutes.
The DAB chromogen was used as the substrate. All sections were counterstained with hematoxylin QS (Vector Laboratories Inc, Burlingame, CA, USA), and examined under light microscopy with a grid eyepiece.
Negative control sections were treated similarly but without primary antibodies. In this study, no statistically differences were On the other hand, high levels of mRNA and IFN-g have been found in different samples (gingival tissue, serum, saliva, and GCF) of CP patients when compared to HS. [14] [15] [16] [17] [18] [19] This study found high levels of IFN-g in the gingival tissues of CP patients when compared to HS, corroborating these studies. We must highlight that only Górska, et al. 
